𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients

✍ Scribed by Moshe Tishler; Dan Caspi; Beno Fishel; Michael Yaron

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
259 KB
Volume
31
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The effect of folic acid and folinic aci
The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis
✍ Sarah L. Morgan; Robert A. Oster; Jeannette Y. Lee; Graciela S. AlarcΓ³n; Joseph πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 1 views

## Abstract ## Objective To determine if folinic acid supplementation during methotrexate (MTX) therapy for rheumatoid arthritis (RA) reduces both urinary 5‐aminoimidazole‐4‐carboxamide (AICA) and urinary adenosine excretion more than does folic acid supplementation. AICA and adenosine are markers

Effect of food on the bioavailability of
Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis
✍ D. Oguey; F. KΓΆlliker; N. J. Gerber; J. Reichen πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 355 KB πŸ‘ 2 views

Objective. To evaluate the influence of food on the bioavailability of an oral dose of methotrexate in patients with rheumatoid arthritis. Methods. Methotrexate (15 mg) was given intravenously and orally, with or without a meal, to 10 patients. Blood samples were drawn at specific intervals to eval

Lymphoma in rheumatoid arthritis: The ef
Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti–tumor necrosis factor therapy in 18,572 patients
✍ Frederick Wolfe; Kaleb Michaud πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 118 KB πŸ‘ 2 views

## Abstract ## Objective The risk of lymphoma is increased in patients with rheumatoid arthritis (RA), and spontaneous reporting suggests that methotrexate (MTX) and anti–tumor necrosis factor (anti‐TNF) therapy might be associated independently with an increased risk of lymphoma. However, data fr